Understanding ER‑phagy’s role in proteostasis reveals a conserved mechanism that can be targeted to promote healthy ageing and extend lifespan across species.
The endoplasmic reticulum, a central hub for protein folding and quality control, undergoes striking structural changes as organisms age. Recent cross‑species investigations reveal a consistent reduction in ER mass and a transition from densely packed sheets to more dispersed tubular networks. This remodeling is orchestrated by selective autophagy of ER components—ER‑phagy—primarily mediated by the Atg8 conjugation system. By coupling high‑resolution imaging with proteomic atlases, scientists have demonstrated that these alterations are not merely by‑products of cellular decline but are actively regulated processes.
Crucially, the study identifies two molecular brakes on age‑related ER‑phagy: the transmembrane protein TMEM‑131 and the IRE‑1‑XBP‑1 signaling axis. Both pathways are essential for the longevity benefits conferred by mTOR inhibition in C. elegans, suggesting that fine‑tuning ER‑phagy can amplify lifespan‑extending interventions. The tissue‑specific triggers uncovered in the worm model hint at a nuanced network where selective ER‑phagy receptors adapt to distinct cellular demands, potentially explaining why broad macroautophagy is universally linked to longevity while selective ER‑phagy mechanisms have been slower to emerge.
From a therapeutic perspective, these findings open avenues for modulating proteostasis in age‑related diseases. Enhancing adaptive ER‑phagy early in life may bolster cellular resilience, whereas preventing excessive remodeling later could mitigate the antagonistic pleiotropy that contributes to neurodegeneration and metabolic dysfunction. As the field moves toward targeted autophagy modulators, the conserved nature of ER‑phagy across yeast, worms, and mammals positions it as a promising lever for extending healthspan in humans.
Comments
Want to join the conversation?
Loading comments...